BMPR2 and pulmonary hypertension: Bone morphogenetic proteins are thought to affect the vascular endothelium and smooth muscle, interfering with transforming growth factor beta signaling; therefore, mutation in BMPR2 is a cause of pulmonary hypertension [21].